General MedicationsINJECTIONStandard

IRINOTECAN HYDROCHLORIDE

Standard Dose

40MG/2ML (20MG/ML)

Max Dose

Refer to approved labeling

Primary Use

Review priority: UNKNOWN Marketing status: Prescription

Summary

Approval overview IRINOTECAN HYDROCHLORIDE is listed in Drugs@FDA under application 213278 (ANDA).

Review priority: UNKNOWN Marketing status: Prescription Active ingredient IRINOTECAN HYDROCHLORIDE Form and strength INJECTABLE;INJECTION - 40MG/2ML (20MG/ML) Sponsor EUGIA PHARMA Submission history Latest submission status date: 2022-04-11 00:00:00.

Structured Monograph

Clinical summary

Approval overview IRINOTECAN HYDROCHLORIDE is listed in Drugs@FDA under application 213278 (ANDA). Review priority: UNKNOWN Marketing status: Prescription Active ingredient IRINOTECAN HYDROCHLORIDE Form and strength INJECTABLE;INJECTION - 40MG/2ML (20MG/ML) Sponsor EUGIA PHARMA Submission history Latest submission status date: 2022-04-11 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Prescription
• Review priority: UNKNOWN

Interaction Notes

No interaction notes stored yet.